New study sheds light on mysterious immune disease in adults
NCT ID NCT03117010
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is following 81 adults with a rare condition called hemophagocytic lymphohistiocytosis (HLH), where the immune system becomes dangerously overactive. Researchers aim to better understand the disease's features and how patients respond to treatments like steroids and chemotherapy. Participants will be regularly monitored by doctors to track their progress and outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
RECRUITINGSeoul, 135-710, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Large study aims to uncover best treatments for lymphoma patients with dangerous immune reaction
- New HLH registry aims to unlock secrets of rare immune disease
- New hope for adults with HLH: gentler treatment combo under study
- Massive registry launched to see if Blood-Filtering device helps sickest patients
- New study aims to crack the code of autoimmune diseases
- New transplant method aims to cut dangerous immune reaction in half-matched donors